Genetic Insights Fueling Drug Discovery and Precision Health

This session highlights how human genetics is accelerating therapeutic discovery and advancing precision health. Talks will feature cutting-edge approaches--from large-scale exome sequencing to multimodal genetic analyses--that are driving target identification, drug development, and patient stratification. Both academic and industry-led efforts will be showcased, illustrating the growing impact of human genetics across the therapeutic pipeline.

Learning Objectives

*    Evaluate how human genetic variation informs therapeutic target identification and drug development strategies
*    Analyze the role of rare and common variants in predicting patient-specific responses to treatment